Postoperative conformal radiotherapy of locally advanced squamous-cell oropharyngeal cancer

Cover Page

Cite item

Full Text

Abstract

The study objective is to demonstrate the necessity of individual selection of radiation plan in patients with locally advanced squamous-cell oropharyngeal cancer after multicomponent operation to decrease radioreactions and radiation injuries.

Materials and methods. The study included data on 64 patients with primary locally advanced oropharyngeal cancer after combination treatment at the Nizhny Novgorod Regional Clinical Oncological Dispensary in 2013–2018.  Radiation treatment was performed after surgeries. The 1st group included 30 patients who underwent conformal radiation using linear accelerators. The 2nd  group included 34 patients who underwent conventional radiation.

Results. For conformal radiotherapy, grade I mucositis was observed in 2 (6.6 %) patients, grade II – in 25 (83.4 %) patients, grade III– IV – in 3 (10 %) patients. In the 1st group, radioreactions developed at dose 30 Gy, in the 2nd group at 20 Gy. In the 2nd group, radioreactions were more severe. Grade II mucositis after conventional radiation were observed in 21 (61.7 %) patients, grade III–IV – in 13 (38.3 %) patients, among them 8 (23.5%) received split-course radiotherapy. Partial necrosis of the flap was detected in 1 (3.3 %) patient in the 1st group and in 4 (2.9 %) patients in the 2nd group.

Conclusion. Conformal radiotherapy, including modulated intensity, is characterized by better isodose distribution with minimal effect on the surrounding healthy tissue and vascular pedicle of the transplant after multicomponent operations. This type of radiation allows to decrease the risk of radioreactions and complications requiring expensive accompanying therapy or even split-course treatment.

About the authors

N. V. Kanishcheva

Nizhny Novgorod Regional Clinical Oncologic Dispensary

Email: fake@neicon.ru
ORCID iD: 0000-0002-0161-1896

11/1 Delovaya St., Nizhniy Novgorod 603126.

Russian Federation

D. V. Sikorsky

Nizhny Novgorod Regional Clinical Oncologic Dispensary

Author for correspondence.
Email: sikorski-d@mail.ru
ORCID iD: 0000-0002-5475-1219

11/1 Delovaya St., Nizhniy Novgorod 603126.

Russian Federation

D. V. Skamnitsky

Nizhny Novgorod Regional Clinical Oncologic Dispensary

Email: fake@neicon.ru
ORCID iD: 0000-0003-1959-8359

11/1 Delovaya St., Nizhniy Novgorod 603126.

Russian Federation

К. V. Bazanov

Nizhny Novgorod Regional Clinical Oncologic Dispensary

Email: fake@neicon.ru
ORCID iD: 0000-0001-5932-282X

11/1 Delovaya St., Nizhniy Novgorod 603126.

Russian Federation

A. V. Maslennikova

Privolzhskiy Research Medical University

Email: fake@neicon.ru
ORCID iD: 0000-0003-0434-4372

10/1 Minin & Pozharsky Sq., Nizhny Novgorod 603950.

Russian Federation

S. О. Podvyaznikov

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Email: fake@neicon.ru
ORCID iD: 0000-0003-1341-0765
Bld. 1, 2/1 Barrikadnaya St., Moscow 125993. Russian Federation

References

  1. Therapeutic radiology: national guidelines. Ed. By A.D. Kaprin, Yu.S. Mardynsky. Moscow: Geotar-Media, 2018. 704 p. (In Russ.).
  2. Cancer of the oropharynx. Clinical guidelines. Available at: http://oncology-association.ru/files/clinical-guidelines_adults%C2%A0-%20projects2018/rak_rotoglotki_pr2018.pdf. (In Russ.).
  3. QUANTEC Summary. Available at: http://radio-oncology.com/doc/tablitsa-quantec-summary.doc.
  4. Tkachev S.I., Alieva S.B. Chemoradiotherapy of locally advanced squamous cell head and neck cancer. Vestnik RONC im. N.N. Blokhina RAMN = Journal of N.N. Blokhin Russian Cancer Research Center RAMS 2006;17(2 S1):50–51. (In Russ.).
  5. Gevorkov A.R., Boykо A.V., Bolotinа L.V., Shashkov S.V. Basic principles of managing radiation and drug induced mucositis and dermatitis for oropharyngeal squamouscell carcinoma. Opukholi golovy i shei = Head and Neck Tumors 2016;6(3):12–21. (In Russ.).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.